| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Franchising Business Model and Regulations; Are We Helping the Consumers Yet? |
|
Advice You - Franchising Business Model and Regulations; Are We Helping the Consumers Yet?
In the United States we have many folks that wish to realize their American Dream and to many people that means owning a b According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product usiness of their own. We also have rules and regulations that are to enforce the franchising model, but are we truly helpi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in g the consumer from the Big Bad Corporate Franchisors out to get the little guys? Well it turns out that Franchising has lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ne of the lowest fraud rates of any business model in America and there really is not real crime or fraud going on. Oh, su here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e there are a few cases now and again where some franchisor failed to fill out a form correctly or something of this natur d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e, but in reality there is not criminal intent. Mostly market place differences of opinion between franchisors and franchi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ees; so are the Federal Regulatory bodies doing their regulating properly? The whole thing is a sham really in my opinion easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi help the consumer? No, most of what the regulatory bodies do end up costing the consumer, as any fines or penalties are p nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ssed onto buyers anyway and also any lawyer fees incurred. It just raises the cost of the future franchise fees. When the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ regulatory bodies modify the laws after such cases and all the lawyers get paid, the regulators will re-define what they p ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eviously defined that led to the law of unintended consequences causing the conflict in the first place. Indeed it is a c ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a uster muck of biblical proportions much worse than the Spaghetti Bowl they call a freeway there. What happens to the 23-ye dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r old kids working in these regulatory agencies? Well, as they learn all this from the inside they do fine until they see cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin what the real world is and leave for private practice. After all Franchising is about the market place, not imposed rules tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rought forth by bureaucrats at the request of stodgy old industry which cannot compete because they do not hustle, have no t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel talent or simply have become lazy and out of shape and now they are not good enough to compete in changing business world. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Here learn about franchising in your spare time if you must; y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 100001.pdf" target="_blank">http://www.ftc.gov/os/comments/franrulestaffrpt/OL-100001.pdf Perhaps you will get a kick . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de out of that because I sure enjoyed letting them have it for their abuse of power and ridiculous blob of bureaucracy in fra elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip chising. No business person should have to endure such a sham in my opinion, so perhaps you will consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Telework and Telecommuting Positive Effects on the Environment Acting Lesson to be an Successful Actor Benefits of Maintaining a Career Portfolio
|